Dr. Sarah Holte

powered by
COS Expertiseź
Fred Hutchinson Cancer Research Center
Public Health Sciences Division
Biostatistics
Senior Staff Scientist
Professional Headshot of Sarah  Holte

Mailing Address

1100 Olive Way
5th Floor
Seattle, Washington 98101
United States

Contact Information

Phone: (206) 667-6975
Fax: (206) 667-4812
sarah@scharp.org

Qualifications

Ph.D., University of Oregon, Mathematics, 1990.
M.A., University of Oregon, Mathematics, 1987.
B.A., University of Minnesota, Mathematics, 1984.

Expertise and Research Interests

Director of Statistical Center for Acute/Early HIV Infection Network (AIEDRP). Supervise management and
analysis of data from studies of Acute and Early HIV Infection. Responsible for both Seattle unit and the core network which includes seven additional units. Serve on the AIEDRP Executive Committee and chair the AIEDRP Data Base working group.

Conduct research using differential and difference equations to model the biology of HIV and the immune system. Includes development of statistical methods for parameter estimation in models of this type.

Lead statistician on a variety of studies of methods for preventing HIV transmission and studies of early infection with HIV and pediatric HIV.

Hire and supervise masters level statisticians, post-doctoral fellows and graduate students who assist with statistical support for SCHARP studies and mathematical modeling projects.

Keywords

COS Keywords:

Biostatistics, HIV, Mathematical Biology, Mathematics.

Additional Terms:

Biostatistics, Mathematical Biology.

Memberships

Society for Industrial and Applied Mathematics

Previous Positions

1993-1995, Post Doctoral Fellow, University of Washington, School of Public Health and Community Medicine, Biostatistics
1990-1995, Assistant Professor, University of Missouri-Rolla, Mathematics
1990-1990, Visiting Instructor, University of Wyoming, College of Arts & Sciences, Mathematics
1985-1990, Graduate Teaching Fellow, University of Oregon, College of Arts and Sciences (CAS), Mathematics

Funding Received

  • Missouri Research Board: Modeling Dynamical Systems With Inverse Limits, 10,000, Jun 1, 1993 to Aug 31, 1994.
  • Oak Ridge Associated Universities (ORAU): Junior Faculty Enhancement Award, 12,000, Jun 1, 1992 to Aug 31, 1993.

Publications

  • Holte S, Frenkel L, Melvin A, Mullins J (2006) Dependant Decay in HIV-1 Dynamics, Journal of AIDS, 41 (3), 266-276
  • Tobin NH, Learn GH, Holte SE, Wang Y, Melvin AJ, McKernan JL, Pawluk DM, Mohan KM, Lewis PF, Mullins JI, Frenkel LM (Aug 2005) Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus, Journal of Virology, 79 (15), 9625-34
  • Wang CC, Holte S, Huang ML, Sacks SL, Engelberg R, Ferrenberg J, Shuhart M, Corey L (Sep 2004) Kinetics of hepatitis B viral load during 48 weeks of treatment with 600 mg vs 100 mg of lamivudine daily, Journal of Viral Hepatitis, 11 (5), 443-7
  • Liu H, Hwangbo Y, Holte S, Lee J, Wang C, Kaupp N, Zhu H, Celum C, Corey L, McElrath MJ, Zhu T (Sep 2004) Analysis of genetic polymorphisms in CCR5, CCR2, stromal cell-derived factor-1, RANTES, and dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin in seronegative individuals repeatedly exposed to HIV-1, The Journal of Infectious Diseases, 190 (6), 1055-8
  • Buchbinder SP, Metch B, Holte SE, Scheer S, Coletti A, Vittinghoff E (May 2004) Determinants of enrollment in a preventive HIV vaccine trial: hypothetical versus actual willingness and barriers to participation, Journal of Acquired Immune Deficiency Syndromes (1999), 36 (1), 604-12
  • Hladik F, Desbien A, Lang J, Wang L, Ding Y, Holte S, Wilson A, Xu Y, Moerbe M, Schmechel S, McElrath MJ (Sep 2003) Most highly exposed seronegative men lack HIV-1-specific, IFN-gamma-secreting T cells, Journal of Immunology (baltimore, Md. : 1950), 171 (5), 2671-83
  • Cao J, McNevin J, Holte S, Fink L, Corey L, McElrath MJ (Jun 2003) Comprehensive analysis of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon-secreting CD8+ T cells in primary HIV-1 infection, Journal of Virology, 77 (12), 6867-78
  • Banks HT, Bortz DM, Holte SE (May 2003) Incorporation of variability into the modeling of viral delays in HIV infection dynamics, Mathematical Biosciences, 183 (1), 63-91
  • Frenkel LM, Wang Y, Learn GH, McKernan JL, Ellis GM, Mohan KM, Holte SE, De Vange SM, Pawluk DM, Melvin AJ, Lewis PF, Heath LM, Beck IA, Mahalanabis M, Naugler WE, Tobin NH, Mullins JI (May 2003) Multiple viral genetic analyses detect low-level human immunodeficiency virus type 1 replication during effective highly active antiretroviral therapy, Journal of Virology, 77 (10), 5721-30
  • Malhotra U, Holte S, Zhu T, Delpit E, Huntsberry C, Sette A, Shankarappa R, Maenza J, Corey L, McElrath MJ (Feb 2003) Early induction and maintenance of Env-specific T-helper cells following human immunodeficiency virus type 1 infection, Journal of Virology, 77 (4), 2663-74
  • Seage GR 3rd, Holte S, Gross M, Koblin B, Marmor M, Mayer KH, Lenderking WR (Dec 2002) Case-crossover study of partner and situational factors for unprotected sex, Journal of Acquired Immune Deficiency Syndromes (1999), 31 (4), 432-9
  • Little SJ, Holte S, Routy JP, Daar ES, Markowitz M, Collier AC, Koup RA, Mellors JW, Connick E, Conway B, Kilby M, Wang L, Whitcomb JM, Hellmann NS, Richman DD (Aug 2002) Antiretroviral-drug resistance among patients recently infected with HIV, The New England Journal of Medicine, 347 (6), 385-94
  • Zhu T, Muthui D, Holte S, Nickle D, Feng F, Brodie S, Hwangbo Y, Mullins JI, Corey L (January 2002) Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy, Journal of Virology, 76 (2), 707-16
  • Holte S, Inverse limits of Markov interval maps, Topology and It's Applications, 123, 421-427, 2002
  • Zhao LP, Davidov O, Quiaoit F, Hsu L, Holte S (2002) Combined association, segregation, and aggregation analysis on case- control family studies, Biostatistics, 3 (3), 315-329
  • Seage GR 3rd, Holte SE, Metzger D, Koblin BA, Gross M, Celum C, Marmor M, Woody G, Mayer KH, Stevens C, Judson FN, McKirnan D, Sheon A, Self S, Buchbinder SP (April 2001) Are US populations appropriate for trials of human immunodeficiency virus vaccine? The HIVNET Vaccine Preparedness Study, American Journal of Epidemiology, 153 (7), 619-27
  • Malhotra U, Holte S, Dutta S, Berrey MM, Delpit E, Koelle DM, Sette A, Corey L, McElrath MJ (February 2001) Role for HLA class II molecules in HIV-1 suppression and cellular immunity following antiretroviral treatment, Journal of Clinical Investigation, 107 (4), 505-17
  • Koblin BA, Holte S, Lenderking B, Heagerty P (August 2000) Readiness for HIV vaccine trials: changes in willingness and knowledge among high-risk populations in the HIV network for prevention trials. The HIVNET Vaccine Preparedness Study Protocol, Journal of Acquired Immune Deficiency Syndromes (1999), 24 (5), 451-7
  • Gross M, Holte SE, Marmor M, Mwatha A, Koblin BA, Mayer KH (August 2000) Anal sex among HIV-seronegative women at high risk of HIV exposure. The HIVNET Vaccine Preparedness Study 2 Protocol Team, Journal of Acquired Immune Deficiency Syndromes (1999), 24 (4), 393-8
  • Metzger DS, Koblin B, Turner C, Navaline H, Valenti F, Holte S, Gross M, Sheon A, Miller H, Cooley P, Seage GR 3rd (July 2000) Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team, American Journal of Epidemiology, 152 (2), 99-106
  • Gross M, Holte S, Seage GR 3rd, Buchbinder SP, Metzger DS, Mayer KH (February 2000) Feasibility of chemoprophylaxis studies in high risk HIV-seronegative populations, Aids Education and Prevention : Official Publication of the International Society for Aids Education, 12 (1), 71-8
  • Holte S, Emerman M (2000) A Competition Model for Viral Inhibition of Host Cell Proliferation, Mathematical Biosciences, 166, 69-84
  • Gross M, Buchbinder SP, Holte S, Celum CL, Koblin BA, Douglas JM Jr (November 1999) Use of reality 'female condoms' for anal sex by US men who have sex with men. HIVNET Vaccine Preparedness Study Protocol Team, American Journal of Public Health, 89 (11), 1739-41
  • Gross M, Buchbinder SP, Holte S, Celum CL, Koblin BA, Douglas Jm Jr (November 1999) Use of Reality 'female condoms' for anal sex by US men who have sex with men, American Journal of Public Health, 89 (11), 1739-41
  • Zhao LP, Hsu L, Holte S, Chen Y, Quiaoit F (1998) Aggregation analysis of family data from case control studies, Biometrika, 85 (2), 299-315
  • Hagensee ME, Kiviat N, Critchlow CW, Hawes SE, Kuypers J, Holte S, Galloway DA (September 1997) Seroprevalence of human papillomavirus types 6 and 16 capsid antibodies in homosexual men, Journal of Infectious Diseases, 176 (3), 625-31
  • Habel LA, Moe RE, Daling JR, Holte S, Rossing MA, Weiss NS, Risk of contralateral breast cancer among women with carcinoma in situ of the breast, Annals of Surgery, 225(1), 69-75, January 1997
  • Holte S, Quiaoit F, Hsu L, Davidov O, Zhao LP, A population based family study of a common oligogenic disease--Part I: Association/aggregation analysis, Genetic Epidemiology, 14(6), 803-7, 1997
  • Zhao LP, Quiaoit F, Hsu L, Davidov O, Holte S (1997) A population-based family study (II): Segregation analysis, Genetic Epidemiology, 14 (6), 945-9
  • Holte S, A new characterization of local trees, Bull Pol Acad Sci, 65, 199-206, 1995
  • Holte S, Full attracting sets of annulus maps which are inverse limits of circles, Top Appl, 65, 49-56, 1995
  • Barge M, Holte S, Nearly one-dimensional Henon attractors, Nonlinearity, 8, 29-42, 1995
  • Holte S, Embedding inverse limits of nearly Markov interval maps as attractors of plaŹnar diffeomrophisms, Colloquium Mathematicum, 68, 291-296, 1995
  • Holte S, Roe R (1994) Inverse limits associated with the forced van der Pol equation, J Diff Eqns Dyn Sys, 6, 601-612
  • Holte S, An order-theoretic characterization of Peano continua, Proceedings of the American Mathematical Society, 115, 1119-1127, 1992
  • Holte S (1992) Generalized horseshoe maps and inverse limits, Pac J Math, 156, 297-305

Profile Details

Last Updated: 8/22/2006

COS Expertise ID #1059238
Reference this profile directly: http://myprofile.cos.com/sarahholte